Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 14190 | 721 | 39.9 | 87% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CDC25B | Author keyword | 62 | 65% | 8% | 59 |
| 2 | CDC25A | Author keyword | 22 | 37% | 6% | 46 |
| 3 | AUTOSCHIZIS | Author keyword | 21 | 78% | 2% | 14 |
| 4 | CDC25 PHOSPHATASE | Author keyword | 15 | 56% | 2% | 18 |
| 5 | P423 | Author keyword | 13 | 80% | 1% | 8 |
| 6 | CDC25B PHOSPHATASE | Author keyword | 12 | 75% | 1% | 9 |
| 7 | CDC25 INHIBITOR | Author keyword | 12 | 86% | 1% | 6 |
| 8 | CDC25 PHOSPHATASES | Author keyword | 9 | 64% | 1% | 9 |
| 9 | CDC25 INHIBITORS | Author keyword | 8 | 75% | 1% | 6 |
| 10 | CDC25 | Author keyword | 7 | 18% | 5% | 35 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CDC25B | 62 | 65% | 8% | 59 | Search CDC25B | Search CDC25B |
| 2 | CDC25A | 22 | 37% | 6% | 46 | Search CDC25A | Search CDC25A |
| 3 | AUTOSCHIZIS | 21 | 78% | 2% | 14 | Search AUTOSCHIZIS | Search AUTOSCHIZIS |
| 4 | CDC25 PHOSPHATASE | 15 | 56% | 2% | 18 | Search CDC25+PHOSPHATASE | Search CDC25+PHOSPHATASE |
| 5 | P423 | 13 | 80% | 1% | 8 | Search P423 | Search P423 |
| 6 | CDC25B PHOSPHATASE | 12 | 75% | 1% | 9 | Search CDC25B+PHOSPHATASE | Search CDC25B+PHOSPHATASE |
| 7 | CDC25 INHIBITOR | 12 | 86% | 1% | 6 | Search CDC25+INHIBITOR | Search CDC25+INHIBITOR |
| 8 | CDC25 PHOSPHATASES | 9 | 64% | 1% | 9 | Search CDC25+PHOSPHATASES | Search CDC25+PHOSPHATASES |
| 9 | CDC25 INHIBITORS | 8 | 75% | 1% | 6 | Search CDC25+INHIBITORS | Search CDC25+INHIBITORS |
| 10 | CDC25 | 7 | 18% | 5% | 35 | Search CDC25 | Search CDC25 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | COMBINED VITAMIN C | 18 | 67% | 2% | 16 |
| 2 | CYCLE ACTIVATING PHOSPHATASES | 11 | 100% | 1% | 6 |
| 3 | MITOTIC INDUCER | 11 | 26% | 5% | 35 |
| 4 | PHASE INHIBITION | 9 | 83% | 1% | 5 |
| 5 | SYNERGISTIC ANTITUMOR ACTIVITY | 8 | 35% | 3% | 19 |
| 6 | G1 S TRANSITION | 7 | 20% | 5% | 34 |
| 7 | MENADIONE 2 METHYL 1 4 NAPHTHOQUINONE | 6 | 33% | 2% | 16 |
| 8 | 14 3 3 PROTEIN BINDING | 6 | 33% | 2% | 16 |
| 9 | K VITAMIN | 6 | 71% | 1% | 5 |
| 10 | HEPATOMA CELL GROWTH | 4 | 67% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| CDC25 phosphatases in cancer cells: key players? Good targets? | 2007 | 268 | 147 | 59% |
| Cdc25 phosphatases and cancer | 2004 | 180 | 57 | 75% |
| CDC25 Phosphatase Inhibitors: An Update | 2012 | 24 | 67 | 79% |
| What's new on CDC25 phosphatase inhibitors | 2007 | 43 | 42 | 76% |
| CDC25A phosphatase: a rate-limiting oncogene that determines genomic stability | 2008 | 41 | 19 | 47% |
| Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review | 2010 | 22 | 81 | 60% |
| Regulating mammalian checkpoints through Cdc25 inactivation | 2003 | 207 | 68 | 37% |
| CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy | 2009 | 15 | 107 | 58% |
| Dual-specificity phosphatases as targets for antineoplastic agents | 2002 | 96 | 120 | 53% |
| Synthetic small molecule Cdc25 phosphatases inhibitors | 2008 | 7 | 53 | 87% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LBCMCP | 6 | 23% | 3.1% | 22 |
| 2 | LBCMCP UMR5088 | 5 | 54% | 1.0% | 7 |
| 3 | BIOL CHEM FUNDAMENTAL MED | 4 | 67% | 0.6% | 4 |
| 4 | TOXICOL CANC BIOL GRP | 4 | 31% | 1.5% | 11 |
| 5 | UNITE PMNT 7369 | 3 | 100% | 0.4% | 3 |
| 6 | ATONE DEV | 3 | 60% | 0.4% | 3 |
| 7 | DRUGS SCREENING | 3 | 60% | 0.4% | 3 |
| 8 | BIOQUIM EXPT | 3 | 35% | 0.8% | 6 |
| 9 | UMR5088 | 3 | 30% | 1.0% | 7 |
| 10 | EA 3940 | 2 | 67% | 0.3% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000156431 | CAK//CDC2//CYCLIN A1 |
| 2 | 0.0000097067 | CHK1//RAD9//CLASPIN |
| 3 | 0.0000095437 | MKP 1//MAP KINASE PHOSPHATASE//DUAL SPECIFICITY PHOSPHATASE |
| 4 | 0.0000092243 | POLAROGRAPHIC CATALYTIC WAVE//MENADIONE SODIUM BISULFITE//ADSORPTIVE CATALYTIC VOLTAMMETRY |
| 5 | 0.0000073369 | VITAMIN K//PHYLLOQUINONE//MENAQUINONE 4 |
| 6 | 0.0000070548 | LAVENDAMYCIN//STREPTONIGRIN//1 4 NAPHTHOQUINONE |
| 7 | 0.0000066913 | POLO LIKE KINASE 1//POLO BOX DOMAIN//PLK1 |
| 8 | 0.0000064475 | PTP1B//PROTEIN TYROSINE PHOSPHATASE//PROTEIN TYROSINE PHOSPHATASE 1B |
| 9 | 0.0000056072 | VAPOCHROMIC BEHAVIOR//HYDROXY NAPHTHOQUINONE//NAPHTHOSEMIQUINONE |
| 10 | 0.0000055199 | MELK//MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE//MAK V HUNK PROTEIN KINASE |